Advertisement

Index by author

February 01, 1996; Volume 276,Issue 2

  1. Barker, L A

    1. Characterization of the antinociceptive properties of cimetidine and a structural analog.
      B Y Li, J W Nalwalk, L A Barker, P Cumming, M E Parsons and L B Hough
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 500-508;

  2. Barnette, M S

    1. Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B.
      C D Manning, M M McLaughlin, G P Livi, L B Cieslinski, T J Torphy and M S Barnette
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 810-818;

  3. Barrett, R J

    1. Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors.
      P L Martin, R J Wysocki, R J Barrett, J M May and J Linden
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 490-499;

  4. Basbaum, A I

    1. Differential contribution of descending controls to the antinociceptive actions of kappa and mu opioids: an analysis of formalin-evoked C-fos expression.
      K R Gogas, J D Levine and A I Basbaum
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 801-809;

  5. Bauman, J L

    1. Cocaine concentration-effect relationship in the presence and absence of lidocaine: evidence of competitive binding between cocaine and lidocaine.
      D Liu, R J Hariman and J L Bauman
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 568-577;

  6. Beaven, M A

    1. Sustained activation of phospholipase D via adenosine A3 receptors is associated with enhancement of antigen- and Ca(2+)-ionophore-induced secretion in a rat mast cell line.
      H Ali, O H Choi, P F Fraundorfer, K Yamada, H M Gonzaga and M A Beaven
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 837-845;

  7. Beck, G

    1. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.
      E H Ohlstein, P Nambi, A Lago, D W Hay, G Beck, K L Fong, E P Eddy, P Smith, H Ellens and J D Elliott
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 609-615;

  8. Bejanian, M

    1. Low level hyperbaric antagonism of diazepam's locomotor depressant and anticonvulsant properties in mice.
      D L Davies, M Bejanian, E S Parker, J Mørland, M B Bolger, R D Brinton and R L Alkana
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 667-675;

  9. Belknap, J K

    1. Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay.
      J S Mogil, B Kest, B Sadowski and J K Belknap
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 532-544;

  10. Bhatt, R K

    1. Effects of metabolites of leukotriene B4 on human neutrophil migration and cytosolic calcium levels.
      W S Powell, J Rokach, S P Khanapure, S Manna, M Hashefi, S Gravel, R J Macleod, J R Falck and R K Bhatt
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 728-736;
« Previous (Pages : 1 2 3 4 5 6 7 ... 31) Next »
Back to top

In this issue

Advertisement